National Cancer Institute's (NCI) Central Institutional Review Board (CIRB) using facilitated review. The NCI CIRB was designed to 1) improve access to NCI-sponsored Cooperative Group clinical trials for potential study participants and their physicians by enabling local IRBs to rapidly approve clinical trials through the use of a facilitated review process; 2) enhance the protection of study participants by providing consistent expert IRB review at the national level; and 3) reduce the administrative burden for local IRBs and research staff. Since this Institution has completed enrollment in the CIRB Initiative by submitting a completed CIRB Application, submitting two signed Authorization Agreements, and including the CIRB on the Institution's FWA, the local IRB and investigators may take advantage of the CIRB's reviews.
Please contact Tiffany Coleman with any questions.
Please click here for policies regarding external IRB's.